11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome
Open accessThe DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Abstract
Context: Androgen excess is a defining feature of polycystic ovary syndrome (PCOS), but the exact origin of hyperandrogenemia remains a matter of debate. Recent studies have highlighted the importance of the 11-oxygenated C19 steroid pathway to androgen metabolism in humans. In this study, we analyzed the contribution of 11-oxygenated androgens to androgen excess in women with PCOS. Methods: One hundred fourteen women with PCOS and 49 healthy control subjects underwent measurement of serum androgens by liquid chromatography-tandem mass spectrometry. Twenty-four–hour urinary androgen excretion was analyzed by gas chromatography-mass spectrometry. Fasting plasma insulin and glucose were measured for homeostatic model assessment of insulin resistance. Baseline demographic data, including body mass index, were recorded. Results: As expected, serum concentrations of the classic androgens testosterone (P < 0.001), androstenedione (P < 0.001), and dehydroepiandrosterone (P < 0.01) were significantly increased in PCOS. Mirroring this, serum 11-oxygenated androgens 11β-hydroxyandrostenedione, 11-ketoandrostenedione, 11β-hydroxytestosterone, and 11-ketotestosterone were significantly higher in PCOS than in control subjects, as was the urinary 11-oxygenated androgen metabolite 11β-hydroxyandrosterone. The proportionate contribution of 11-oxygenated to total serum androgens was significantly higher in patients with PCOS compared with control subjects [53.0% (interquartile range, 48.7 to 60.3) vs 44.0% (interquartile range, 32.9 to 54.9); P < 0.0001]. Obese (n = 51) and nonobese (n = 63) patients with PCOS had significantly increased 11-oxygenated androgens. Serum 11β-hydroxyandrostenedione and 11-ketoandrostenedione correlated significantly with markers of insulin resistance. Conclusions: We show that 11-oxygenated androgens represent the majority of circulating androgens in women with PCOS, with close correlation to markers of metabolic risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“11KA4 is the next most abundant 11-oxygenated androgen precursor in circulation (Table 2) [39,41,68,69,289].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [41]
The cited source says what the claim attributes to it.
In the citing paper
“While the levels of 11-oxygenated androgens and their precursors have been shown to be significantly elevated in patients with polycystic ovary syndrome (PCOS) and 21-hydroxylase deficiency [41,69], one study reported that the circulating levels of 11KT were also higher than that of testosterone in a healthy female control group (BMI 21.2–26.1 kg/m2) [41].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [41]
The cited source says what the claim attributes to it.
In the citing paper
“The significant levels of 11KA4 measured in the serum of healthy premenopausal woman (O'Reilly et al., 2016) supports the involvement of peripheral tissue such as the kidney, especially considering that the adrenal expresses only low levels of HSD11B2 (Coulter et al., 1999).”
From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as O'Reilly et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“Notably, the androgen profile in endometriosis, as described in our study, is different from that reported for PCOS.13”
From Steroid hormone profiling reveals altered adrenal androgen production in endometriosis (2026) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“In PCOS, median concentrations of 11OHA4, and 11KA4, as reported by O’Reilly et al., are 31.7 nmol/L and 13.4 nmol/L, respectively, and are increased relative to healthy controls.”
From Steroid hormone profiling reveals altered adrenal androgen production in endometriosis (2026) · cites this paper as [13]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
Conway, G., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Franks, S., Gambineri, A., Kelestimur, F., Macut, D., Micic, D., Pasquali, R., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0253 · Cited by 676
Arlt, W., Walker, E. A., Draper, N., Ivison, H. E., Ride, J. P., Hammer, F., Chalder, S. M., Borucka-Mankiewicz, M., Hauffa, B. P., Malunowicz, E. M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16503-3 · Cited by 345
Self-citationO'Reilly, M. W., Taylor, A. E., Crabtree, N. J., Hughes, B. A., Capper, F., Crowley, R. K., Stewart, P. M., Tomlinson, J. W., & Arlt, W. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3399 · Cited by 283
Self-citationTurcu, A. F., Nanba, A. T., Chomic, R., Upadhyay, S. K., Giordano, T. J., Shields, J. J., Merke, D. P., Rainey, W. E., & Auchus, R. J. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1181 · Cited by 231
Rege, J., Nakamura, Y., Satoh, F., Morimoto, R., Kennedy, M. R., Layman, L. C., Honma, S., Sasano, H., & Rainey, W. E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2912 · Cited by 227
Storbeck, K.-H., Bloem, L. M., Africander, D., Schloms, L., Swart, P., & Swart, A. C. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.07.006 · Cited by 198
Self-citationQuinkler, M., Sinha, B., Tomlinson, J. W., Bujalska, I. J., Stewart, P. M., & Arlt, W. (2004) · Journal of Endocrinology · doi:10.1677/joe.1.05762 · Cited by 190
Self-citation
Cited by
Items 101–200 of 268
Sumińska, M., Bogusz‐Górna, K., Wegner, D., & Fichna, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134622 · Cited by 28
Barnard, L., Nikolaou, N., Louw, C., Schiffer, L., Gibson, H., Gilligan, L. C., Gangitano, E., Snoep, J., Arlt, W., Tomlinson, J. W., et al. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2020.105724 · Cited by 25
Self-citation11-Oxyandrogens in Adolescents With Polycystic Ovary Syndrome
Taylor, A. E., Ware, M. A., Breslow, E., Pyle, L. L., Severn, C., Nadeau, K. J., Chan, C. L., Kelsey, M. M., & Cree‐Green, M. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac037 · Cited by 33
Self-citationApproach to the Patient: Diagnostic Challenges in the Workup for Polycystic Ovary Syndrome
Joham, A. E., Tay, C. T., Laven, J. S. E., Louwers, Y. V., & Azziz, R. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae910 · Cited by 36
Steroid hormone levels vary with sex, aging, lifestyle, and genetics
Deltourbe, L. G., Sugrue, J. A., Maloney, E., Dubois, F., Jaquaniello, A., Bergstedt, J., Patin, É., Quintana‐Murci, L., Ingersoll, M. A., & Duffy, D. (2025) · Science Advances · doi:10.1126/sciadv.adu6094 · Cited by 33
Oakes, J., Li, N., Wistow, B., Griffin, A., Barnard, L., Storbeck, K., Cunliffe, V. T., & Krone, N. P. (2019) · Endocrinology · doi:10.1210/en.2019-00068 · Cited by 23
Self-citationNon-PCOS Hyperandrogenic Disorders in Adolescents
Esquivel-Zuniga, M. R., Kirschner, C. K., McCartney, C. R., & Solorzano, C. M. B. (2022) · Seminars in Reproductive Medicine · doi:10.1055/s-0041-1742259 · Cited by 31
Nowotny, H. F., Auer, M. K., Lottspeich, C., Schmidt, H., Dubinski, I., Bidlingmaier, M., Adaway, J., Hawley, J., Keevil, B., & Reisch, N. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab446 · Cited by 22
Altinkilic, E. M., du Toit, T., Sakin, Ö., Attar, R., Groessl, M., & Flück, C. E. (2023) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2023.106366 · Cited by 22
Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women
Elhassan, Y., Hawley, J. M., Cussen, L., Abbara, A., Clarke, S. A., Kempegowda, P., Dhillon‐Smith, R. K., Thadani, P., Busby, M., Owusu‐Darkwah, L., et al. (2025) · Clinical Endocrinology · doi:10.1111/cen.15265 · Cited by 31
Self-citationPeripheral blood mononuclear cells preferentially activate 11-oxygenated androgens
Schiffer, L., Bossey, A., Kempegowda, P., TAYLOR, A. E. R., Akerman, İ., Scheel‐Toellner, D., Storbeck, K., & Arlt, W. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1077 · Cited by 25
Self-citationBioactivity of 11 keto and hydroxy androgens in yeast and mammalian host cells
Handelsman, D. J., Cooper, E. R., & Heather, A. K. (2022) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.106049 · Cited by 22
11β-Hydroxylase loss disrupts steroidogenesis and reproductive function in zebrafish
Oakes, J., Barnard, L., Storbeck, K., Cunliffe, V. T., & Krone, N. P. (2020) · Journal of Endocrinology · doi:10.1530/joe-20-0160 · Cited by 22
Self-citationWalzer, D., Turcu, A. F., Jha, S., Abel, B. S., Auchus, R. J., Merke, D. P., & Brown, R. J. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac365 · Cited by 24
Zhang, X., Xu, H., Feng, G., Yang, L., Zhao, L., Li, R., & Zhao, R. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.11.025 · Cited by 23
Nakao, H., Yokomoto‐Umakoshi, M., Nakatani, K., Umakoshi, H., Ogata, M., Fukumoto, T., Kaneko, H., Iwahashi, N., Fujita, M., Ogasawara, T., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104733 · Cited by 25
Torchen, L. C., Sisk, R. K., Legro, R. S., Turcu, A. F., Auchus, R. J., & Dunaif, A. E. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa532 · Cited by 22
MANAGEMENT OF ENDOCRINE DISEASE Hyperandrogenic states in women: pitfalls in laboratory diagnosis
PUGEAT, M. M., Plotton, I., de la Perrière, A. B., Raverot, G., Déchaud, H., & Raverot, V. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0776 · Cited by 22
Schiffer, L., Adaway, J., Arlt, W., & Keevil, B. G. (2019) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563219847498 · Cited by 22
Self-citationWeger, M., Diotel, N., Weger, B. D., Beil, T., Zaucker, A., Eachus, H., Oakes, J., do Rego, J. L., Storbeck, K., Gut, P., et al. (2018) · Journal of Neuroendocrinology · doi:10.1111/jne.12586 · Cited by 25
Self-citationSwart, A. C., du Toit, T., Gourgari, E., Kidd, M., Keil, M. F., Faucz, F. R., & Stratakis, C. A. (2020) · Pediatric Research · doi:10.1038/s41390-020-0870-1 · Cited by 21
Circadian Rhythms of 11-Oxygenated C19 Steroids and 5-Steroid Sulfates in Healthy Men
Turcu, A. F., Zhao, L., Chen, X., Yang, R., Rege, J., Rainey, W. E., Veldhuis, J. D., & Auchus, R. J. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0348 · Cited by 19
Dumesic, D. A., Turcu, A. F., Liu, H., Grogan, T., Abbott, D. H., Lu, G., Dharanipragada, D., & Chazenbalk, G. D. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad079 · Cited by 20
Exploring the Predictive Role of 11‐Oxyandrogens in Diagnosing Polycystic Ovary Syndrome
Mody, A., Lodish, M. B., Auchus, R. J., Turcu, A. F., Jiang, F., & Huddleston, H. G. (2025) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70022 · Cited by 21
Dumesic, D. A., Tulberg, A., McNamara, M. A., Grogan, T., Abbott, D. H., Naik, R., Lu, G., & Chazenbalk, G. D. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab158 · Cited by 18
Cussen, L., McDonnell, T., Miller, C., McIlroy, M., & O’Reilly, M. (2025) · Reproduction · doi:10.1530/rep-25-0102 · Cited by 22
Self-citationAlimajstorovic, Z., Westgate, C. S. J., Jensen, R., Eftekhari, S., Mitchell, J., Vijay, V., Seneviratne, S. Y., Mollan, S. P., & Sinclair, A. J. (2020) · Eye · doi:10.1038/s41433-019-0751-1 · Cited by 19
DHEA and polycystic ovarian syndrome: Meta-analysis of case-control studies
Benjamin, J. J., Kuppusamy, M., Koshy, T., Maruthy, K. N., & Padmavathi, R. (2021) · PLoS ONE · doi:10.1371/journal.pone.0261552 · Cited by 21
Key signalling pathways underlying the aetiology of polycystic ovary syndrome
Walters, K. A., Moreno-Asso, A., Stepto, N. K., Pankhurst, M. W., Paris, V. R., & Rodgers, R. J. (2022) · Journal of Endocrinology · doi:10.1530/joe-22-0059 · Cited by 19
Wang, Z., van Faassen, M. H. J. R., Groen, H., Cantineau, A. E., van Oers, A. M., van der Veen, A., Hawley, J. M., Keevil, B. G., Kema, I. P., & Hoek, A. (2024) · Human Reproduction · doi:10.1093/humrep/deae058 · Cited by 23
Zhang, X., Xu, H., Zhou, C., Yang, L., Zhai, S., Yang, P., Zhao, R., & Li, R. (2022) · Journal of Chromatography B · doi:10.1016/j.jchromb.2022.123188 · Cited by 17
11-Keto-testosterone and Other Androgens of Adrenal Origin
Stárka, L., Dušková, M., & Vítků, J. (2020) · Physiological Research · doi:10.33549/physiolres.934516 · Cited by 16
11-Ketotestosterone is a major androgen produced in porcine adrenal glands and testes
Yazawa, T., Sato, T., Nemoto, T., Nagata, S., Imamichi, Y., Kitano, T., Sekiguchi, T., Uwada, J., Islam, M. S., Mikami, D., et al. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105847 · Cited by 16
Schiffer, L., Oestlund, I., Snoep, J. L., Gilligan, L. C., TAYLOR, A. E. R., Sinclair, A. J., Singhal, R., Freeman, A., Ajjan, R., Tiganescu, A., et al. (2024) · The FASEB Journal · doi:10.1096/fj.202302131r · Cited by 18
Self-citationdu Toit, T., van Rooyen, D., Stander, M. A., Atkin, S. L., & Swart, A. C. (2020) · Journal of Chromatography B · doi:10.1016/j.jchromb.2020.122243 · Cited by 15
Fu, C., Chen, M., Zhang, W., Yin, H., Chen, G., Huang, Q., Yang, X., Chen, L., Lin, C., & Yin, G. (2021) · Journal of Ovarian Research · doi:10.1186/s13048-021-00781-5 · Cited by 17
Janner, M., Sommer, G., Groessl, M., & Flück, C. E. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa598 · Cited by 18
Lee, C., O’Day, P., Stouffer, D. G., Auchus, R. J., & Turcu, A. F. (2025) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2025.106717 · Cited by 16
Reference intervals for serum 11-oxygenated androgens in children
Adriaansen, B. P. H., Oude-Alink, S., Swinkels, D. W., Schröder, M. A. M., Span, P. N., Sweep, F. C. G. J., der Grinten, H. L. C., & van Herwaarden, A. E. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae008 · Cited by 18
Biomediators in Polycystic Ovary Syndrome and Cardiovascular Risk
Pandurevic, S., Μacut, D., Fanelli, F., Pagotto, U., & Gambineri, A. (2021) · Biomolecules · doi:10.3390/biom11091350 · Cited by 17
Human Adrenal Cortex: Epigenetics and Postnatal Functional Zonation
Baquedano, M. S., & Belgorosky, A. (2018) · Hormone Research in Paediatrics · doi:10.1159/000487995 · Cited by 16
11-Ketotestosterone is the predominant active androgen in prostate cancer patients after castration
Snaterse, G., van Dessel, L. F., van Riet, J., TAYLOR, A. E. R., van der Vlugt‐Daane, M., Hamberg, P., de Wit, R., Visser, J. A., Arlt, W., Lolkema, M. P., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.148507 · Cited by 23
Self-citationHoteit, B. H., Kotaich, J., Ftouni, H., Hazime, F., Safawi, A., Masri, R., & Marwani, M. (2025) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188251383064 · Cited by 21
Rajska, A., Raczak‐Gutknecht, J., Struck‐Lewicka, W., Buszewska‐Forajta, M., Wityk, P., Verding, P., Kowalewska, A., Siluk, D., Rachoń, D., & Markuszewski, M. J. (2024) · Journal of Chromatography A · doi:10.1016/j.chroma.2024.464735 · Cited by 14
Auer, M. K., Hawley, J. M., Lottspeich, C., Bidlingmaier, M., Sappl, A., Nowotny, H. F., Tschaidse, L., Treitl, M., Reincke, M., Keevil, B. G., et al. (2022) · European Journal of Endocrinology · doi:10.1530/eje-22-0518 · Cited by 16
Understanding hirsutism in PCOS
Oliveira, T. F., & Comim, F. V. (2024) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2024.2310558 · Cited by 20
Characterizing skeletal muscle dysfunction in women with polycystic ovary syndrome
McDonnell, T., Cussen, L., McIlroy, M., & O’Reilly, M. (2022) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188221113140 · Cited by 18
Self-citationSkiba, M. A., Bell, R. J., Islam, R. M., Karim, M. N., & Davis, S. R. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa063 · Cited by 12
Rohayem, J., Zitzmann, M., Laurentino, S., Kliesch, S., Nieschlag, E., Holterhus, P., & Kulle, A. E. (2020) · Clinical Endocrinology · doi:10.1111/cen.14324 · Cited by 12
Mutation of HSD3B2 Gene and Fate of Dehydroepiandrosterone
Baquedano, M. S., Guercio, G., Costanzo, M., Marino, R. M., Rivarola, M. A., & Belgorosky, A. (2018) · Vitamins and hormones · doi:10.1016/bs.vh.2018.05.002 · Cited by 14
Nagasaki, K., Takase, K., Numakura, C., Homma, K., Hasegawa, T., & Fukami, M. (2020) · Human Reproduction · doi:10.1093/humrep/deaa221 · Cited by 14
Scannell, N., Villani, A., Moran, L., & Mantzioris, E. (2025) · Proceedings of the Nutrition Society · doi:10.1017/s0029665124007584 · Cited by 12
The Role of 11-Oxygenated Androgens and Endocrine Disruptors in Androgen Excess Disorders in Women
Vítků, J., Varausova, A., Škodová, T., Kolátorová, L., Vosátková, M., Včelák, J., Vrbíková, J., Šimková, M., & Dušková, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179691 · Cited by 14
Naigaonkar, A., Dadachanji, R., Kumari, M., & Mukherjee, S. (2024) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2024.2430775 · Cited by 16
Rittig, N. F., Arlien-Søborg, M. C., Svart, M. V., Thomsen, H. H., Kirkegaard, K., Greve, V. H., Nielsen, M. M., Stochholm, K., Ørnstrup, M. J., & Gravholt, C. H. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf106 · Cited by 12
Circulating steroids and mood disorders in patients with polycystic ovary syndrome
Yoshida, T., Saito, K., Kawamura, T., Ishikawa, T., Kato, T., Matsubara, K., Miyasaka, N., Miyado, M., & Fukami, M. (2020) · Steroids · doi:10.1016/j.steroids.2020.108748 · Cited by 12
Yan, M.-Q., Wang, Y., Wang, Z., Liu, X.-H., Yang, Y., Duan, X., Sun, H. Q., & Liu, X. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad034 · Cited by 12
Gunness, A., Pazderska, A., Ahmed, M., McGowan, A., Phelan, N., Boran, G. P., TAYLOR, A. E. R., O’Reilly, M., Arlt, W., Moore, K., et al. (2018) · Human Reproduction · doi:10.1093/humrep/dey243 · Cited by 12
Self-citationDavis, S. R., Turcu, A. F., Robinson, P. J., & Bell, R. J. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2018-00412 · Cited by 10
Rzewuska, N., Kunicki, J., Pieniak, K., Laskus, P., Zabielska, B. A., Smolarczyk, R., & Kunicki, M. (2023) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2023.11.005 · Cited by 14
Scott, S. N., Siguencia, M., Stanczyk, F. Z., Hartmann, M. F., Wudy, S. A., White, M. L., Chung, W. K., Santella, R. M., Terry, M. B., & Houghton, L. C. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad161 · Cited by 11
Livadas, S., Yıldız, B. O., Mastorakos, G. P., Gambineri, A., Pignatelli, D., Giorgino, F., Andersen, M., Obermayer-Pietsch, B., Μacut, D., ESE PCOS Special Interest Group, et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae085 · Cited by 14
Popovic, M., Monnerat, S., TAYLOR, A. E. R., Gilligan, L. C., Schiffer, L., Arlt, W., Vogt, D., Geyter, C. D., Hutter, N., Donath, M. Y., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1435698 · Cited by 12
Self-citationBiochemical classification diagnosis of polycystic ovary syndrome based on serum steroid hormones
Wang, M., Zhang, S., He, J., Zhang, T., Zhu, H., Sun, R., & Yang, N. (2024) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2024.106626 · Cited by 14
Torchen, L. C., Wu, M., Thompson, B., & Beaudouin, A. (2025) · Reproduction · doi:10.1530/rep-25-0091 · Cited by 16
Zhang, X., Zhou, C., Xu, H., Feng, Y., Yang, P., Zhai, S., Song, J., & Yang, L. (2020) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2020.113680 · Cited by 10
He, X., Banker, M. M., Puttabyatappa, M., Padmanabhan, V., & Auchus, R. J. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab793 · Cited by 12
Zeidler, R. B., Biemann, R., Ceglarek, U., Kratzsch, J., Isermann, B., & Gaudl, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010539 · Cited by 12
Huynh, K., Kempegowda, P., Tamblyn, J. A., Reilly, M., Mueller, J. W., Hewison, M., & Jenkinson, C. (2021) · Steroids · doi:10.1016/j.steroids.2021.108812 · Cited by 10
Self-citationHan, B., Zhu, H., Yao, H., Ren, J., O’Day, P., Wang, H., Zhu, W., Cheng, T., Auchus, R. J., & Qiao, J. (2021) · Clinical and Translational Science · doi:10.1111/cts.13184 · Cited by 12
Pignatelli, D., Azziz, R., & Yıldız, B. O. (2022) · doi:10.1093/med/9780198870197.003.0161 · Cited by 10
Canonical and Noncanonical Androgen Metabolism and Activity
Storbeck, K., & Mostaghel, E. A. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-32656-2_11 · Cited by 11
Self-citationGashaw, I., Reif, S., Wiesinger, H., Kaiser, A., Zollmann, F. S., Scheerans, C., Grevel, J., Piraino, P., Seidel, H., Peters, M., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad063 · Cited by 9
Self-citationLi, H., Tu, Y., Xie, W., Shi, X., Zhang, Q., Lin, J., Zhong, Y., Lin, Z., & Cai, Z. (2024) · Microchimica Acta · doi:10.1007/s00604-024-06355-8 · Cited by 11
Kim, J. H., Lee, Y. A., Lim, Y.-H., Lee, K., Kim, B.-N., Kim, J. I., Hong, Y., Yang, S. W., Song, J., & Shin, C. H. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa498 · Cited by 9
Adrenal and Polycystic Ovary Syndrome
Çelik, Ö., & Yıldız, B. O. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108989831.008 · Cited by 9
Dumesic, D. A., Rasouli, M. A., Katz, J. D., Lu, G., Dharanipragada, D., Turcu, A. F., Grogan, T., Flores, K., Magyar, C. E., Abbott, D. H., et al. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae162 · Cited by 9
Negahdari, F. M., Hadjzadeh, M., Gholamnezhad, Z., Noshahr, Z. S., & Keshavarzi, Z. (2021) · PubMed Central · doi:10.22038/ajp.2021.55679.2785 · Cited by 11
Ma, C., Xu, H., Zhang, X., Feng, G., Shi, L., Yuan, S., Li, Y., Zhao, R., & Qiao, J. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117440 · Cited by 9
LC-MS/MS the First 20 years: A Personal View
Keevil, B. G. (2021) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/00045632211040059 · Cited by 8
Ridder, L. O. R., Just, J., Hvas, C. L., Nielsen, M. M., Møller, H. J., Grønbæk, H., & Gravholt, C. H. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf059 · Cited by 6
Snaterse, G., van Dessel, L. F., TAYLOR, A. E. R., Visser, J. A., Arlt, W., Lolkema, M. P., & Hofland, J. (2021) · Steroids · doi:10.1016/j.steroids.2021.108800 · Cited by 10
Self-citationDevelopmental origins of polycystic ovary syndrome: Everything starts in utero
Abbott, D. H., Greinwald, E. P., & Levine, J. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823045-9.00009-2 · Cited by 12
Sexual dimorphism in benign adrenocortical tumours
Suntornlohanakul, O., Ronchi, C., Arlt, W., & Prete, A. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf088 · Cited by 7
Self-citationTomkins, M., McDonnell, T., Cussen, L., Sagmeister, M. S., Oestlund, I., Shaheen, F., Harper, L., Hardy, R., TAYLOR, A. E. R., Gilligan, L. C., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae714 · Cited by 7
Self-citationOsteoblasts Generate Testosterone From DHEA and Activate Androgen Signaling in Prostate Cancer Cells
Moon, H. H., Clines, K. L., O’Day, P., Al-Barghouthi, B. M., Farber, E., Farber, C. R., Auchus, R. J., & Clines, G. A. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4313 · Cited by 8
The ultra-acute steroid response to traumatic injury: a cohort study
Bentley, C., Hazeldine, J., Bravo, L., TAYLOR, A. E. R., Gilligan, L. C., Shaheen, F., Acharjee, A., Gkoutos, G. V., Foster, M., Arlt, W., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad024 · Cited by 7
Self-citation11-Oxyandrogens from the viewpoint of pediatric endocrinology
Fukami, M. (2022) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.2022-0029 · Cited by 7
Tanio, M., Miyamoto, Y., Saka, T., Kudo, Y., Hayashi, R., Kawano, S., Yoshino, Y., Abe, N., Yamaguchi, E., Arai, Y., et al. (2025) · Steroids · doi:10.1016/j.steroids.2025.109692 · Cited by 6
SHBG, Free Testosterone, and Type 2 Diabetes Risk in Middle-aged African Men: A Longitudinal Study
Seipone, I. D., Mendham, A. E., Storbeck, K., Oestlund, I., Kufe, C. N., Chikowore, T., Masemola, M., Crowther, N. J., Kengne, A. P., Norris, S. A., et al. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae129 · Cited by 7
Self-citationThe role of 11-oxygenated androgens in prostate cancer
Snaterse, G., Hofland, J., & Lapauw, B. (2023) · Endocrine Oncology · doi:10.1530/eo-22-0072 · Cited by 9
Cutler, D. A. (2019) · cIRcle (University of British Columbia) · doi:10.14288/1.0378929 · Cited by 6
Zhang, X., Xu, H., Sun, Y., Xiong, X., Liu, L., Yang, L., Zhao, L., Li, X., Li, R., & Zhao, R. (2025) · Talanta Open · doi:10.1016/j.talo.2025.100459 · Cited by 4
Zhao, W., Zhang, J., Feng, A., Yin, H., Liu, C., & Pan, Y. (2022) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.2c00077 · Cited by 4
Raps, M., Kleider, C., & Lehmann, L. (2024) · Steroids · doi:10.1016/j.steroids.2024.109441 · Cited by 5
An expanded metabolic pathway for androgen production by host-associated bacteriaPreprint
Wang, T., Ahmad, S., Cruz-Lebrón, A., Ernst, S. E., Caicedo, K. Y. O., Jeong, Y., Binion, B., Mbuvi, P., Dutta, D., Fernández-Materán, F. V., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.09.598130 · Cited by 4
Prolactin and Adrenal Androgens During Adrenarche
Íñiguez, G., Barnafi, E., Lalli, E., Pereira, A. P. R., Ferrer‐Rosende, P., & Verónica Mericq, G. (2025) · Clinical Endocrinology · doi:10.1111/cen.15227 · Cited by 3
Fujisawa, Y., Sano, S., Murai, Y., Sakaguchi, K., Masunaga, Y., Kinjo, K., Tanikawa, W., Ikeda, M., Oyama, I., & Ogata, T. (2025) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2025.106747 · Cited by 3
Kumar, N., Sharma, N., Roy, S. D., Chawla, I., & Sharma, L. K. (2025) · Advanced Biomedical Research · doi:10.4103/abr.abr_262_23 · Cited by 5
Remarks on the Hormonal Background of the Male Equivalent of Polycystic Ovary Syndrome
Stárka, L., & Dušková, M. (2021) · Prague Medical Report · doi:10.14712/23362936.2021.8 · Cited by 3
Metadata
- Authors
- O’Reilly, M. W., Kempegowda, P., Jenkinson, C., Taylor, A. E., Quanson, J. L., Storbeck, K.-H., & Arlt, W.
- Affiliations
- University of Birmingham (GB)
- Stellenbosch University (ZA)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- Corresponding author
- Arlt, Wiebke
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2016-11-30
- Volume
- 102
- Issue
- 3
- Pages
- 840-848
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC5460696
- OpenAlex
- W2557976244
- Cited by
- 267
- References
- 36
- Citations by year
- 2026: 26 · 2025: 28 · 2024: 24 · 2023: 23 · 2022: 29 · 2021: 38 · 2020: 36 · 2019: 29 · 2018: 25 · 2017: 8
- FWCI
- 27.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by)
- Funders
- Wellcome Trust (099909, 092283)
- Newton Fund
- National Institute for Health and Care Research (ACF-2013-09-001)
- Royal Society
- Academy of Medical Sciences (NAF004\1002)
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Keywords
- polycystic ovary syndrome, hyperandrogenism, hyperandrogenemia, 11β-hydroxyandrostenedione, 11-ketoandrostenedione, 11β-hydroxytestosterone, 11-ketotestosterone, androgen metabolism, insulin resistance, obesity, testosterone, androstenedione, dehydroepiandrosterone
- MeSH terms
- Adult, Androgens, Androstenedione, Androstenes, Blood Glucose, Chromatography, Liquid, Dehydroepiandrosterone, Female, Humans, Hydroxytestosterones, Insulin, Insulin Resistance, Gas Chromatography-Mass Spectrometry, Obesity, Polycystic Ovary Syndrome, Testosterone, Case-Control Studies, Hyperandrogenism, Tandem Mass Spectrometry, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.